Explore more publications!

Missouri Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.

December 2025

January 2026

February 2026

Press releases published on February 11, 2026

Medical Device Contract Manufacturing Set to Reach $155.2 Billion Globally by 2030

an hour ago

Medical Device Contract Manufacturing Set to Reach $155.2 Billion Globally by 2030

GlobeNewswire

OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners

an hour ago

OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners

GlobeNewswire

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

an hour ago

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

GlobeNewswire

Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate

an hour ago

Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate

GlobeNewswire

DIL Walk Foundation Takes National and Global Leadership Role in Advancing Precision Health and Healthspan

an hour ago

DIL Walk Foundation Takes National and Global Leadership Role in Advancing Precision Health and Healthspan

GlobeNewswire

LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026

an hour ago

LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026

GlobeNewswire

Clairity Founder and CEO, Dr. Connie Lehman, Named to TIME’s 2026 TIME100 Health List

an hour ago

Clairity Founder and CEO, Dr. Connie Lehman, Named to TIME’s 2026 TIME100 Health List

GlobeNewswire

Global Pharmaceutical Mass Spectrometry Market Poised to Reach $2.75 Billion by 2031 | MarketsandMarkets™

2 hours ago

Global Pharmaceutical Mass Spectrometry Market Poised to Reach $2.75 Billion by 2031 | MarketsandMarkets™

GlobeNewswire

Psyence BioMed Announces Settlement of Shareholder Litigation

2 hours ago

Psyence BioMed Announces Settlement of Shareholder Litigation

GlobeNewswire

Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma

2 hours ago

Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma

GlobeNewswire

Entera Bio Announces Open Market Purchases of Company Stock by Board Members

2 hours ago

Entera Bio Announces Open Market Purchases of Company Stock by Board Members

GlobeNewswire

VIVUS Advances Patient Access with New Copay Assistance Program for PANCREAZE®

2 hours ago

VIVUS Advances Patient Access with New Copay Assistance Program for PANCREAZE®

GlobeNewswire

CalMHSA Selects Eleos as Statewide AI Technology Partner for Behavioral Health

2 hours ago

CalMHSA Selects Eleos as Statewide AI Technology Partner for Behavioral Health

GlobeNewswire

Counslr Meets School Mental Health Demands with Further National Expansion and Strategic Partnerships

2 hours ago

Counslr Meets School Mental Health Demands with Further National Expansion and Strategic Partnerships

GlobeNewswire

HealthEdge® Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

2 hours ago

HealthEdge® Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

GlobeNewswire

Wesley Pharmaceuticals Launches NAD+, Introducing a Signature Longevity and Skin Health Formulation to Its Product Lineup

2 hours ago

Wesley Pharmaceuticals Launches NAD+, Introducing a Signature Longevity and Skin Health Formulation to Its Product Lineup

GlobeNewswire

Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

2 hours ago

Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

GlobeNewswire

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline

2 hours ago

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline

GlobeNewswire

Outlook Therapeutics Submits Type A Meeting Request to FDA Following Complete Response Letter

2 hours ago

Outlook Therapeutics Submits Type A Meeting Request to FDA Following Complete Response Letter

GlobeNewswire

$Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)$

3 hours ago

Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

GlobeNewswire